Updated News

Researchers from various universities in Iraq analyzed the different benefits and challenges of using CRISPR-Cas to target miRNA in Cancer. They also offered advanced strategies that can be used to overcome potential issues. CRISPR-Cas can be used to insert permanent mutations in the genome that can be transferred to the next generation of cells.